Silencing of Gene Expression by Gymnotic Delivery of Antisense Oligonucleotides
Antisense oligodeoxyribonucleotides have been used for decades to achieve sequence-specific silencing of gene expression. However, all early generation oligonucleotides (e.g., those with no other modifications than the phosphorothioate backbone) are inactive in vitro unless administered using a delivery vehicle. These delivery vehicles are usually lipidic but can also be polyamines or some other particulate reagent. We have found that by employing locked nucleic acid (LNA) phosphorothioate gap-mer nucleic acids of 16 mer or less in length, and by carefully controlling the plating conditions of the target cells and duration of the experiment, sequence-specific gene silencing can be achieved at low micromolar concentrations in vitro in the absence of any delivery vehicle. This process of naked oligonucleotide delivery to achieve gene silencing in vivo, which we have termed gymnosis, has been observed in many both adherent and nonadherent cell lines against several different targets genes.
- Application of 2D-DIGE in Cancer Proteomics Toward Personalized Medicine
- In Vivo Reprogramming of Human Telomerase Reverse Transcriptase (hTERT) by Trans-Splicing Ribozyme to Target Tumor Cells
- Biochemical Analysis of Long Terminal Repeat Retrotransposons
- Three-Dimensional Analysis of Molecular Signals with Episcopic Imaging Techniques
- Isolation of Target Gene Promoter/Enhancer Sequences by Whole Genome PCR Method
- Circulating MicroRNAs in the Cerebrospinal Fluid of Patients with Brain Diseases
- Functional Genomics by cDNA Subtractive Hybridization
- Cytochrome P450-Based Gene Therapies for Cancer
- Low-Resolution Typing of HLA-DQA1 Using DNA Microarray
- Mendelian Randomisation: A Tool for Assessing Causality in Observational Epidemiology